Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
This report summarizes three phase I studies evaluating volasertib, a polo-like kinase inhibitor, plus azacitidine in adults with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, or acute myeloid leukemia. |